UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000030846
Receipt number R000035216
Scientific Title Nutrition-related factors associated with waiting list mortality in patients with interstitial lung disease
Date of disclosure of the study information 2018/01/17
Last modified on 2018/01/17 09:31:44

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Nutrition-related factors associated with waiting list mortality in patients with interstitial lung disease

Acronym

Factors associated with waitlist mortality

Scientific Title

Nutrition-related factors associated with waiting list mortality in patients with interstitial lung disease

Scientific Title:Acronym

Factors associated with waitlist mortality

Region

Japan


Condition

Condition

interstitial lung disease
chronic respiratory disease

Classification by specialty

Pneumology Chest surgery Adult

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

To find nutrition-related markers with waiting list mortality

Basic objectives2

Others

Basic objectives -Others

association with wait list mortality and body compositions, serum albumin and serum transthyretin

Trial characteristics_1


Trial characteristics_2


Developmental phase



Assessment

Primary outcomes

to assess the relationship of nutrition-related factors with waiting list mortality

Key secondary outcomes



Base

Study type

Observational


Study design

Basic design


Randomization


Randomization unit


Blinding


Control


Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms


Purpose of intervention


Type of intervention


Interventions/Control_1


Interventions/Control_2


Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

18 years-old <=

Age-upper limit


Not applicable

Gender

Male and Female

Key inclusion criteria

1. interstitial lung disease

Key exclusion criteria

1. severe comorbidities
2. lung transplantation from living donors during hospitalization before registration to JOTN
3. hospitalization for a second lung transplantation
4. registration at another hospital
5. failure to meet the JOTN criteria
6. severe mental disorders
7. alcoholism
8. smoking
9. incomplete data

Target sample size

75


Research contact person

Name of lead principal investigator

1st name
Middle name
Last name Shinichi Harashima

Organization

Kyoto University

Division name

Diabetes, Endocrinology and Nutrition

Zip code


Address

54 Shogoin Kawahara-cho Sakyo-ku Kyoto

TEL

0757513560

Email

harasima@kuhp.kyoto-u.ac.jp


Public contact

Name of contact person

1st name
Middle name
Last name Toyofumi F. Chen-Yoshikawa

Organization

Kyoto University

Division name

Thoracic Surgery

Zip code


Address

54 Shogoin Kawahara-cho Sakyo-ku Kyoto

TEL

0757514975

Homepage URL


Email

fengshic@kuhp.kyoto-u.ac.jp


Sponsor or person

Institute

Kyoto University

Institute

Department

Personal name



Funding Source

Organization

Kyoto University Grant

Organization

Division

Category of Funding Organization

Other

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization


Address


Tel


Email



Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2018 Year 01 Month 17 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Completed

Date of protocol fixation

2013 Year 04 Month 01 Day

Date of IRB


Anticipated trial start date

2013 Year 05 Month 01 Day

Last follow-up date

2016 Year 05 Month 31 Day

Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information

Seventy-six patients were screened; among them, 48 fulfilled the inclusion criteria.
The final analysis target was 40.
Median observational period was 497 (range 97-1015) days; median survival time was 550 (95% CI 414-686) days.
Mortality rate was 38.7/100 person-years.


Management information

Registered date

2018 Year 01 Month 17 Day

Last modified on

2018 Year 01 Month 17 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000035216


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name